| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.082 | 0.1 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.085 | 0.1 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |